Design, Synthesize and Bio-Evaluate 1,2-Dihydroisoquinolin-3(4<i>H</i>)-One Derivates as Acetylcholinesterase and <i>β</i>-Secretase Dual Inhibitors in Treatment with Alzheimer’s Disease

Journals Menu

Follow SCIRP

ISSN Print: 2327-5081
ISSN Online: 2327-509X
www.scirp.org/journal/jbm
E-mail: jbm@scirp.org

"Design, Synthesize and Bio-Evaluate 1,2-Dihydroisoquinolin-3(4H)-One Derivates as Acetylcholinesterase and β-Secretase Dual Inhibitors in Treatment with Alzheimer’s Disease"
written by Youchao Deng, Yuren Jiang, Xiongjie Zhao, Jinlian Wang,
published by Journal of Biosciences and Medicines, Vol.4 No.1, 2016

has been cited by the following article(s):

[1]	Small Peptides Targeting BACE-1, AChE, and A-β Reversing Scopolamine-Induced Memory Impairment: A Multitarget Approach against Alzheimer's Disease
	ACS omega, 2024

[2]	Alzheimer's Disease: Treatment of Multi-Factorial Disorders with Multi-Target Approach
	Mini Reviews in Medicinal Chemistry, 2023

[3]	Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer's Disease: From In Silico to In Vivo
	International Journal of …, 2022

[4]	Dual-target compounds for Alzheimer's disease: natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR)
	2021

[5]	Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases
	2020

[6]	A new and facile approach to 1, 2-dihydroisoquinolin-3 (4 H)-imines by the Cu (i)-catalyzed reaction of 2-ethynylbenzyl methanesulfonates, sulfonyl azides …
	RSC Advances, 2018

[7]	Multi-targeting strategies for Alzheimer's disease therapeutics: pros and cons
	Current Topics in Medicinal Chemistry, 2017

[1]	Recent advancements in the therapeutic approaches for Alzheimer's disease treatment: current and future perspective RSC Medicinal Chemistry, 2025 DOI:10.1039/D4MD00630E

[2]	Small Peptides Targeting BACE-1, AChE, and A-β Reversing Scopolamine-Induced Memory Impairment: A Multitarget Approach against Alzheimer’s Disease ACS Omega, 2024 DOI:10.1021/acsomega.3c09069

[3]	Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11 Frontiers in Clinical Drug Research - CNS and Neurological Disorders, 2023 DOI:10.2174/9789815123319123110003

[4]	Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases Current Neuropharmacology, 2020 DOI:10.2174/1385272823666191021124443

Follow SCIRP